Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHB2200002	GSK3228836 注射液	bepirovirsen	Injection	Chemical Drugs(1)	Supplementary Application	2022-01-07					view
JXHB2200003	GSK3228836 注射液	bepirovirsen	Injection	Chemical Drugs(1)	Supplementary Application	2022-01-07					view
JXHB2400093	GSK3228836 注射液	bepirovirsen	Injection	Chemical Drugs(1)	Supplementary Application	2024-05-28					view
JXHB2300066	GSK3228836 注射液	bepirovirsen	Injection	Chemical Drugs(1)	Supplementary Application	2023-04-13					view
JXHL2101076	GSK3228836 注射液	bepirovirsen	Injection	Chemical Drugs(1)	Import Drug Application	2021-06-02					view
JXHL2200306	GSK3228836 注射液	bepirovirsen	Injection	Chemical Drugs(1)	Import Drug Application	2022-10-20					view
JXHL2000170	GSK3228836 注射液	bepirovirsen	Injection	Chemical Drugs(1)	Import Drug Application	2020-07-06	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	In Review	2020-07-04	view
JXHL2000310	GSK3228836 注射液	bepirovirsen	Injection	Chemical Drugs(1)	Import Drug Application	2020-11-21	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	In Review	2020-11-20	view